1 results match your criteria: "and Tourkodimitris are with the Forest Research Institute.[Affiliation]"
Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial.
J Am Acad Child Adolesc Psychiatry
July 2009
Dr. Emslie is with the University of Texas Southwestern Medical Center. Drs. Ventura, Korotzer, and Tourkodimitris are with the Forest Research Institute.
Objective: This article presents the results from a prospective, randomized, double-blind, placebo-controlled trial of escitalopram in adolescent patients with major depressive disorder.
Method: Male and female adolescents (aged 12-17 years) with DSM-IV-defined major depressive disorder were randomly assigned to 8 weeks of double-blind treatment with escitalopram 10 to 20 mg/day (n = 155) or placebo (n = 157). The primary efficacy parameter was change from baseline to week 8 in Children's Depression Rating Scale-Revised (CDRS-R) score using the last observation carried forward approach.